4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-298865
Chief Development Officer sold 20,000 shares at an average $93.13 ($1,862,530)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $21.65 | $433,000 | 23,985 | D |
| 2026-07-07 | Sale : show line 2 in the form 10b5-1 | −19,048 | $93.11 | $1,773,481 | 4,937 | D |
| 2026-07-07 | Sale : show line 3 in the form 10b5-1 | −952 | $93.54 | $89,048 | 3,985 | D |
| Open-market sales · 20,000 sh · avg $93.13 · $1,862,530 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-07 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −20,000 | 130,000 | D |
Loading xslF345X06/ownership.xml…